Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 5
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2283)
- Volume 19, 2023 (66)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 5, 2009
In-hospital resuscitation: opioids and other factors influencing survival
Karamarie Fecho, Freeman Jackson, Frances Smith, et al
Therapeutics and Clinical Risk Management 2009, 5:961-968
Published Date: 8 December 2009
Monitored anesthesia care (MAC) sedation: clinical utility of fospropofol
Eric A Harris, David A Lubarsky, Keith A Candiotti
Therapeutics and Clinical Risk Management 2009, 5:949-959
Published Date: 8 December 2009
Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient onsiderations and the role of lisdexamfetamine
Brian J Cowles
Therapeutics and Clinical Risk Management 2009, 5:943-948
Published Date: 7 December 2009
An evidence-based review of natalizumab therapy in the management of Crohn’s disease
Raja GR Edula, Michael F Picco
Therapeutics and Clinical Risk Management 2009, 5:935-942
Published Date: 19 November 2009
Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist
James P Kemp
Therapeutics and Clinical Risk Management 2009, 5:923-934
Published Date: 19 November 2009
The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab
Richard Kelly, Stephen Richards, Peter Hillmen, et al
Therapeutics and Clinical Risk Management 2009, 5:911-921
Published Date: 18 November 2009
Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability
Andre R Brunoni, Renerio Fraguas Jr, Felipe Fregni
Therapeutics and Clinical Risk Management 2009, 5:897-910
Published Date: 17 November 2009
Celecoxib in arthritis: relative risk management profile and implications for patients
Gayle McKellar, Gurkirpal Singh
Therapeutics and Clinical Risk Management 2009, 5:889-896
Published Date: 9 November 2009
New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat
James E Wraith, Jackie Imrie
Therapeutics and Clinical Risk Management 2009, 5:877-887
Published Date: 3 November 2009
Fesoterodine for the treatment of urinary incontinence and overactive bladder
Pamela Ellsworth
Therapeutics and Clinical Risk Management 2009, 5:869-876
Published Date: 3 November 2009
Update on the use of deferasirox in the management of iron overload
Ali Taher, Maria Domenica Cappellini
Therapeutics and Clinical Risk Management 2009, 5:857-868
Published Date: 30 October 2009
Pediatric psoriasis: an update
Nanette B Silverberg
Therapeutics and Clinical Risk Management 2009, 5:849-856
Published Date: 21 October 2009
The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea
Hoonmo L Koo, Herbert L DuPont, David B Huang
Therapeutics and Clinical Risk Management 2009, 5:841-848
Published Date: 21 October 2009
Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem
Fausto de Lalla
Therapeutics and Clinical Risk Management 2009, 5:829-839
Published Date: 14 October 2009
Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
E Michael Lewiecki
Therapeutics and Clinical Risk Management 2009, 5:817-827
Published Date: 14 October 2009
Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
Stephan Ehrhardt, Christian G Meyer
Therapeutics and Clinical Risk Management 2009, 5:805-815
Published Date: 6 October 2009
The role of urate and xanthine oxidase in vascular oxidative stress: future directions
Jacob George, Allan Struthers
Therapeutics and Clinical Risk Management 2009, 5:799-803
Published Date: 5 October 2009
Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
Melissa K Osborn
Therapeutics and Clinical Risk Management 2009, 5:789-798
Published Date: 1 October 2009
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer
Serena Ricciardi, Silverio Tomao, Filippo de Marinis
Therapeutics and Clinical Risk Management 2009, 5:781-787
Published Date: 25 September 2009
Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures
Jun Iwamoto, Atsushi Miyata, Yoshihiro Sato, et al
Therapeutics and Clinical Risk Management 2009, 5:773-779
Published Date: 25 September 2009
Alglucosidase alfa: Long term use in the treatment of patients with Pompe disease
Michael Beck
Therapeutics and Clinical Risk Management 2009, 5:767-772
Published Date: 21 September 2009
Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety
Christoph Kellinghaus
Therapeutics and Clinical Risk Management 2009, 5:757-766
Published Date: 21 September 2009
Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease
NM Wiles, J Howard
Therapeutics and Clinical Risk Management 2009, 5:745-755
Published Date: 21 September 2009
Dyslipidemia in Iranian overweight and obese children
Robabeh Ghergerehchi
Therapeutics and Clinical Risk Management 2009, 5:739-743
Published Date: 18 September 2009
Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a review
Alain Monnier
Therapeutics and Clinical Risk Management 2009, 5:725-738
Published Date: 11 September 2009
Anticholinergic syndrome following an unintentional overdose of scopolamine
Carmela E Corallo, Ann Whitfield, Adeline Wu
Therapeutics and Clinical Risk Management 2009, 5:719-723
Published Date: 13 September 2009
Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review
S Deandrea, O Corli, I Moschetti, et al
Therapeutics and Clinical Risk Management 2009, 5:707-718
Published Date: 4 September 2009
Role of everolimus in the treatment of renal cell carcinoma
Saby George, Ronald M Bukowski
Therapeutics and Clinical Risk Management 2009, 5:699-706
Published Date: 28 August 2009
Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
Joan Khoo, Christopher K Rayner, Karen L Jones, et al
Therapeutics and Clinical Risk Management 2009, 5:683-698
Published Date: 20 August 2009
Comparison of linear–stochastic and nonlinear–deterministic algorithms in the analysis of 15-minute clinical ECGs to predict risk of arrhythmic death
James E Skinner, Michael Meyer, Brian A Nester, et al
Therapeutics and Clinical Risk Management 2009, 5:671-682
Published Date: 18 August 2009
Prophylatic treatment of migraine and migraine clinical variants with topiramate: an update
Sergio Carmona, Osvaldo Bruera
Therapeutics and Clinical Risk Management 2009, 5:661-669
Published Date: 16 August 2009
Managing pediatric hepatitis C: current and emerging treatment options
Wikrom Karnsakul, Mary Kay Alford, Kathleen B Schwarz
Therapeutics and Clinical Risk Management 2009, 5:651-660
Published Date: 13 August 2009
Pegylated liposomal doxorubicin in ovarian cancer
Robert Strother, Daniela Matei
Therapeutics and Clinical Risk Management 2009, 5:639-650
Published Date: 10 August 2009
Epileptic seizure after treatment with thiocolchicoside
Pedro Giavina-Bianchi, Mara Giavina-Bianchi, Luciana Kase Tanno, et al
Therapeutics and Clinical Risk Management 2009, 5:635-637
Published Date: 6 August 2009
Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: a review
W Frank Peacock IV, Jorge E Angeles, Karina M Soto, et al
Therapeutics and Clinical Risk Management 2009, 5:627-634
Published Date: 4 August 2009
Current trends in the treatment of hepatic encephalopathy
Mohamad Rasm Al Sibae, Brendan M McGuire
Therapeutics and Clinical Risk Management 2009, 5:617-626
Published Date: 31 July 2009
Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir
Michael Neely, Andrea Kovacs
Therapeutics and Clinical Risk Management 2009, 5:595-615
Published Date: 31 July 2009
Natalizumab in the treatment of multiple sclerosis
Brandon A Brown
Therapeutics and Clinical Risk Management 2009, 5:585-594
Published Date: 31 July 2009
Management strategies for pulmonary sarcoidosis
Robina Kate Coker
Therapeutics and Clinical Risk Management 2009, 5:575-584
Published Date: 23 July 2009
The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability
Megan N Beatty, Paul D Blumenthal
Therapeutics and Clinical Risk Management 2009, 5:561-574
Published Date: 22 July 2009
Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency
Danilo Fintini, Claudia Brufani, Marco Cappa
Therapeutics and Clinical Risk Management 2009, 5:553-559
Published Date: 16 July 2009
A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
Seyed Ali Sadjadi, James I McMillan, Navin Jaipaul, Patricia Blakely, et al.
Therapeutics and Clinical Risk Management 2009, 5:547-552
Published Date: 10 July 2009
Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
Angela B Smith, Culley C Carson
Therapeutics and Clinical Risk Management 2009, 5:535-545
Published Date: 8 July 2009
Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain
Howard S Smith, Timothy R Deer
Therapeutics and Clinical Risk Management 2009, 5:521-534
Published Date: 6 July 2009
Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis
Devi Mukkai Krishnamurty, Atoosa Rabiee, Sanjay B Jagannath, Dana K Andersen
Therapeutics and Clinical Risk Management 2009, 5:507-520
Published Date: 2 July 2009
Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
Jun Iwamoto, Mitsuyoshi Uzawa, Yoshihiro Sato, Tsuyoshi Takeda, et al.
Therapeutics and Clinical Risk Management 2009, 5:499-505
Published Date: 1 July 2009
Does nonadherence to local recommendations for empirical antibiotic therapy on admission to the intensive care unit have an impact on in-hospital mortality?
Jean-Luc Baudel, Jacques Tankovic, Fabrice Carrat, Cécile Vigneau, et al.
Therapeutics and Clinical Risk Management 2009, 5:491-498
Published Date: 9 July 2009
Guidelines for the treatment of bacterial vaginosis: focus on tinidazole
Laura J Dickey, Michael D Nailor, Jack D Sobel
Therapeutics and Clinical Risk Management 2009, 5:485-489
Published Date: 23 June 2009
Pharmacotherapy of pediatric and adolescent HIV infection
Susan J Schuval
Therapeutics and Clinical Risk Management 2009, 5:469-484
Published Date: 18 June 2009
EUS-guided transmural drainage for peripancreatic fluid collections using fine needle and stiff fine guidewire without electrocautery: An optional safe technique
Hiroyuki Miyatani, Yukio Yoshida
Therapeutics and Clinical Risk Management 2009, 5:465-468
Published Date: 25 June 2009
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Eduardo Pimenta, Suzanne Oparil
Therapeutics and Clinical Risk Management 2009, 5:459-464
Published Date: 17 June 2009
Substitution of anticonvulsant drugs
Bernhard J Steinhoff, Uwe Runge, Otto W Witte, Hermann Stefan, et al.
Therapeutics and Clinical Risk Management 2009, 5:449-457
Published Date: 22 June 2009
The benefits and risks of testosterone replacement therapy: a review
Nazem Bassil, Saad Alkaade, John E Morley
Therapeutics and Clinical Risk Management 2009, 5:427-448
Published Date: 11 June 2009
Treatment of recurrent epithelial ovarian cancer
Carmela Pisano, Giovanni S Bruni, Gaetano Facchini, Claudia Marchetti, et al.
Therapeutics and Clinical Risk Management 2009, 5:421-426
Published Date: 15 June 2009
Role of rasagiline in treating Parkinson’s disease: effect on disease progression
Irene A Malaty, Hubert H Fernandez
Therapeutics and Clinical Risk Management 2009, 5:413-419
Published Date: 25 May 2009
Minimizing cardiac surgery risks in a Hepatitis C patient: Changing surgical strategy after evaluation by modern imaging technologies
Felix Kur, Andres Beiras-Fernandez, Martin Oberhoffer, Konstantin Nikolaou, et al.
Therapeutics and Clinical Risk Management 2009, 5:409-412
Published Date: 21 May 2009
Luteal phase support in assisted reproductive technology treatment: focus on Endometrin® (progesterone) vaginal insert
Jerome H Check
Therapeutics and Clinical Risk Management 2009, 5:403-407
Published Date: 26 May 2009
Recombinant factor VIII in the management of hemophilia A: current use and future promise
Jerry S Powell
Therapeutics and Clinical Risk Management 2009, 5:391-402
Published Date: 19 May 2009
Managing Behçet’s disease: An update on current and emerging treatment options
P LA van Daele, J H Kappen, P M van Hagen, J AM van Laar
Therapeutics and Clinical Risk Management 2009, 5:385-390
Published Date: 13 May 2009
Casopitant: a novel NK1-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting
Christina Ruhlmann, Jørn Herrstedt
Therapeutics and Clinical Risk Management 2009, 5:375-384
Published Date: 11 May 2009
Fatty liver in children
Mandana Rafeey, Fakhrossadat Mortazavi, Nafiseh Mogaddasi, Ghergherehchi Robabeh, et al.
Therapeutics and Clinical Risk Management 2009, 5:371-374
Published Date: 8 May 2009
Once-daily medications for the pharmacological management of ADHD in adults
Oleg v Tcheremissine, Lori M Lieving
Therapeutics and Clinical Risk Management 2009, 5:367-369
Published Date: 11 May 2009
Anthracycline extravasation injuries: management with dexrazoxane
Karin Jordan, Timo Behlendorf, Franziska Mueller, Hans-Joachim Schmoll
Therapeutics and Clinical Risk Management 2009, 5:361-366
Published Date: 8 May 2009
Current trends in the treatment of polycystic ovary syndrome with desire for children
Margalida E Sastre, Maria O Prat, Miguel Angel Checa, Ramon C Carreras
Therapeutics and Clinical Risk Management 2009, 5:353-360
Published Date: 8 May 2009
Mycophenolic acid formulations in adult renal transplantation – update on efficacy and tolerability
Déla Golshayan, M Pascual, Bruno Vogt
Therapeutics and Clinical Risk Management 2009, 5:341-351
Published Date: 30 April 2009
Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection
Christine Katlama, Robert Murphy
Therapeutics and Clinical Risk Management 2009, 5:331-340
Published Date: 30 April 2009
Associations of anemia persistency with medical expenditures in Medicare ESRD patients on dialysis
Jiannong Liu, Haifeng Guo, David Gilbertson, Robert Foley, et al.
Therapeutics and Clinical Risk Management 2009, 5:319-330
Published Date: 22 April 2009
Antimalarials and the fight against malaria in Brazil
Luiz MA Carmargo, Saulo de Oliveira, Sergio Basano, Célia RS Garcia
Therapeutics and Clinical Risk Management 2009, 5:311-317
Published Date: 22 April 2009
Management of glucocorticoids-induced osteoporosis: role of teriparatide
Silvia Migliaccio, Marina Brama, Nazzarena Malavolta
Therapeutics and Clinical Risk Management 2009, 5:305-310
Published Date: 17 April 2009
Cecal perforation with an ascending colon cancer caused by upper gastrointestinal endoscopy
Hiroyuki Miyatani, Yukio Yoshida, Hirokazu Kiyozaki
Therapeutics and Clinical Risk Management 2009, 5:301-303
Published Date: 3 April 2009
Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women
Sharath Gangadhara, Gianfilippo Bertelli
Therapeutics and Clinical Risk Management 2009, 5:291-300
Published Date: 2 April 2009
Dasatinib in chronic myeloid leukemia: a review
Dolly G Aguilera, Apostolia M Tsimberidou
Therapeutics and Clinical Risk Management 2009, 5:281-289
Published Date: 27 March 2009
Onset of action and seizure control in Lennox-Gaustaut syndrome: focus on rufinamide
Russell P Saneto, Gail D Anderson
Therapeutics and Clinical Risk Management 2009, 5:271-280
Published Date: 26 March 2009
Recombinant human epoetin beta in the treatment of chemotherapy-related anemia
Iain RJ Macpherson, Colin R Lindsay, Nicholas S Reed
Therapeutics and Clinical Risk Management 2009, 5:261-270
Published Date: 16 March 2009
Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
J Wells Logan, Fernando R Moya
Therapeutics and Clinical Risk Management 2009, 5:251-260
Published Date: 12 March 2009
Incidence and causes of neonatal hyperbilirubinemia in a center of Catania
Marco Sciuto, Gaetano Bertino, Mariangela Zocco, Ignazio Vecchio, et al.
Therapeutics and Clinical Risk Management 2009, 5:247-250
Published Date: 12 March 2009
Challenging issues in molecular-targeted therapy
Zoheir Ezziane
Therapeutics and Clinical Risk Management 2009, 5:239-245
Published Date: 3 March 2009
Role of oxaliplatin in the treatment of colorectal cancer
Pasquale Comella, Rossana Casaretti, Claudia Sandomenico, Antonio Avallone, Luca Franco
Therapeutics and Clinical Risk Management 2009, 5:229-238
Published Date: 4 March 2009
Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations
Alberto Borgioli, Christian Viviani, Marco Duvina, Leila Brancato, Giuseppe Spinelli, et al
Therapeutics and Clinical Risk Management 2009, 5:217-227
Published Date: 27 February 2009
Regimen complexity and medication nonadherence in elderly patients
Andrea Corsonello, Claudio Pedone, Fabrizia Lattanzio, Maria Lucchetti, Sabrina Garasto, et al.
Therapeutics and Clinical Risk Management 2009, 5:209-216
Published Date: 26 February 2009
Fludarabine in the treatment of chronic lymphocytic leukemia: a review
Francesca Ricci, Alessandra Tedeschi, Enrica Morra, Marco Montillo
Therapeutics and Clinical Risk Management 2009, 5:187-207
Published Date: 4 March 2009
Tenofovir and its potential in the treatment of hepatitis B virus
Laura Reynaud, Maria Aurora Carleo, Maria Talamo, Guglielmo Borgia
Therapeutics and Clinical Risk Management 2009, 5:177-185
Published Date: 2 February 2009
Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
Roland D Chapurlat
Therapeutics and Clinical Risk Management 2009, 5:169-175
Published Date: 29 January 2009
Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
Maurie Markman
Therapeutics and Clinical Risk Management 2009, 5:161-168
Published Date: 2 February 2009
Role of combination bortezomib and pegylated liposomal doxorubicin in the management of relapsed and/or refractory multiple myeloma
Jatin J Shah, Robert Z Orlowski, Sheeba K Thomas
Therapeutics and Clinical Risk Management 2009, 5:151-159
Published Date: 22 January 2009
Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection
Pranav Dalal, Monica Grafals, Darshika Chhabra, Lorenzo Gallon
Therapeutics and Clinical Risk Management 2009, 5:139-149
Published Date: 13 January 2009
Nd: YAG capsulotomy for posterior capsule opacification after combined clear corneal phacoemulsification and vitrectomy
Ilias Georgalas, Petros Petrou, George Kalantzis, Dimitrios Papaconstantinou, Chrysanthi Koutsandrea, Ioannis Ladas
Therapeutics and Clinical Risk Management 2009, 5:133-137
Published Date: 11 January 2009
Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
Hideki Hasegawa, Takeshi Ichinohe, Akira Ainai, Shin-ichi Tamura, Takeshi Kurata
Therapeutics and Clinical Risk Management 2009, 5:125-132
Published Date: 9 March 2009
A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India
Vidya Nand Rabi Das, Niyamat Ali Siddiqui, Krishna Pandey, Vijay Pratap Singh, Roshan K Topno, et al
Therapeutics and Clinical Risk Management 2009, 5:117-124
Published Date: 16 December 2008
Role of atazanavir in the treatment of HIV infection
Pablo Rivas, Judit Morello, Carolina Garrido, Sonia Rodríguez-Nóvoa, Vincent Soriano
Therapeutics and Clinical Risk Management 2009, 5:99-116
Published Date: 17 December 2008
A review of the use of exemestane in early breast cancer
Andrew Robinson
Therapeutics and Clinical Risk Management 2009, 5:91-98
Published Date: 11 December 2008
Angioid streaks, clinical course, complications, and current therapeutic management
Ilias Georgalas, Dimitris Papaconstantinou, Chrysanthi Koutsandrea, George Kalantzis, Dimitris Karagiannis, et al
Therapeutics and Clinical Risk Management 2009, 5:81-89
Published Date: 9 December 2008
A new extended release formulation (OROS®) of hydromorphone in the management of pain
Sharon M Weinstein
Therapeutics and Clinical Risk Management 2009, 5:75-80
Published Date: 9 December 2008
Treatment and chemoprevention of NSAID-associated gastrointestinal complications
Edward J Frech, Mae F Go
Therapeutics and Clinical Risk Management 2009, 5:65-73
Published Date: 9 December 2008
Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety
Helen Y How, Baha M Sibai
Therapeutics and Clinical Risk Management 2009, 5:55-64
Published Date: 9 December 2008
Life-threatening hemorrhage following subcutaneous heparin therapy
Jana Hudcova, Daniel Talmor
Therapeutics and Clinical Risk Management 2009, 5:51-54
Published Date: 2 December 2008
Topical retapamulin in the management of infected traumatic skin lesions
Ribhi Shawar, Nicole Scangarella-Oman, MaryBeth Dalessandro, John Breton, Monique Twynholm, et al
Therapeutics and Clinical Risk Management 2009, 5:41-49
Published Date: 4 December 2008
Voiding cystourethrogram in the diagnosis of vesicoureteric reflux in children with antenatally diagnosed hydronephrosis
R B Nerli, S S Amarkhed, I R Ravish
Therapeutics and Clinical Risk Management 2009, 5:35-39
Published Date: 2 December 2008
Management of postoperative nausea and vomiting: focus on palonosetron
Neil A Muchatuta, Michael J Paech
Therapeutics and Clinical Risk Management 2009, 5:21-34
Published Date: 30 November 2008
Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab
Ilias Georgalas, Dimitris Papaconstantinou, Ioannis Tservakis, Chrysanthi Koutsandrea, Ioannis Ladas
Therapeutics and Clinical Risk Management 2009, 5:17-19
Published Date: 27 November 2008
Regular use of traditional analgesics predicts major coronary events: A cohort study
Mikko Haara, Markku Heliövaara, Jari PA Arokoski, Paul Knekt, Pirjo Manninen, et al
Therapeutics and Clinical Risk Management 2009, 5:9-15
Published Date: 2 December 2008
Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007
Jennifer D Peterson, Lawrence S Chan
Therapeutics and Clinical Risk Management 2009, 5:1-7
Published Date: 25 November 2008